As LPS-TLR-4 signaling, as well as TLR-4 and HSP interactions are crucial elements in intestinal inflammation [8], our data support the notion that TGF-β2 may protect against intestinal diseases during early life. Here, TGFB2 is linked to intestinal disorder.